Organogenesis Holdings Inc.
ORGO
Last
$1.29
Day
+0.8%
1y
-68.3%
5y
-90.2%
52w
-81.9%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0525d
EMA 21
1.41
EMA 50
1.65
EMA 200
2.53
20d high
-15.2%
5y high
-90.6%
5y range
0th
Positions held
Your positionsORGO isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-6
Hold
avoid
Signal
Sell
Target
$1.40
Stop
$1.18
Stop distance
8.5%
Target vs last
+8.5%
Fundamentals
| Market cap | $164.70M | Enterprise value | $325.42M | Trailing P/E | — | Forward P/E | -4.13 |
| PEG | — | Price / book | 1.11 | Beta | 1.27 | Dividend yield | 0.00% |
| Revenue growth | -56.7% | Earnings growth | — | Gross margin | 71.5% | Operating margin | -119.3% |
| Profit margin | -18.4% | ROE | -25.9% | ROA | -4.1% | Debt / equity | 0.23 |
| Current ratio | 3.52 | Free cash flow | $28.45M | Analyst recommendation | none | Mean target | $2.00 |
| 52w high | $7.08 | 52w low | $1.25 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $42.8M | $36.3M | $225M | $150M | $101M | — |
| Op margin | -121.9% | -190.0% | 29.0% | 14.4% | -10.7% | — |
| Net income | -$96.3M | -$53.2M | $43.7M | $21.6M | -$9.4M | — |
| Gross margin | 44.7% | 28.9% | 77.8% | 75.9% | 72.6% | — |
| Gross profit | $19.1M | $10.5M | $175M | $114M | $73.1M | — |
| Operating income | -$52.2M | -$68.9M | $65.2M | $21.6M | -$10.8M | — |
- Revenue +18% vs prior quarter ($43M vs $36M).
- Gross margin 44.7% (was 28.9% prior quarter).
- Operating margin expanded to -121.9%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $563M | $482M | $433M | $451M | — |
| Op margin | 9.9% | 4.5% | 2.9% | 4.9% | — |
| Net income | $37.0M | $0.9M | $4.9M | $15.5M | — |
| Gross margin | 75.6% | 76.0% | 75.4% | 76.7% | — |
| Gross profit | $426M | $366M | $327M | $346M | — |
| Operating income | $55.9M | $21.5M | $12.5M | $22.3M | — |
Headline scan
Headlines — watch
• [WARN · fundamentals] Organogenesis Holdings (ORGO) Stock Fair Value Moves Lower After Guidance Cut And Analyst Caution
News
2026-08-13 · Organogenesis (ORGO) Q2 2026 Earnings Call Transcript
2026-08-10 · Organogenesis Holdings (ORGO) Stock Fair Value Moves Lower After Guidance Cut And Analyst Caution
2026-08-07 · Organogenesis Holdings Inc. Q2 2026 Earnings Call Summary
2026-08-07 · Organogenesis Q2 Earnings Call Highlights
2026-08-06 · Organogenesis: Q2 Earnings Snapshot
2026-08-06 · Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results
Price (daily)
Full chart · RSI · MACD · patternsORGO · daily-13.5% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin